One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

In a world obsessed with youthful skin and ageless beauty, it’s easy to be tempted by quick fixes and trending treatments.

Slimjaro is a cutting-edge weight loss supplement that is sparking a new conversation around lifestyle-linked weight ...

Sleep Lean also offers a 60-day, no-questions-asked money-back guarantee. If you’re not satisfied with your Sleep Lean ...

Chronic tinnitus is a frustrating condition that affects millions worldwide, characterized by persistent ringing or buzzing ...

Coalition Urges Stronger FDA Front-of-Package Labels on Sugars, Sodium, Fats 28 consumer and health groups plus 12 ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.

Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...